North America Injectable Drug Delivery Market

82 views
72 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
82
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

North America Injectable Drug Delivery Market

  1. 1. N.America Injectable Drug Delivery Market Published : April 2013 No. of Pages: 280 Price: Single User: US$4600 Corporate User: US$7150
  2. 2. New market research Report on “Naval Vessels andSurface Combatants” added to ReportsnReports.comThe North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it isexpected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drugdelivery technologies are the combination of two major segments; devices and formulations. The NorthAmerican injectable drug delivery formulations technologies market was the largest segment in thismarket. In addition, the market is segmented on the basis of its therapeutic applications. In therapeuticarea, hormonal disorders command the major segment of injectable drug delivery technologies marketdue to high demand of injectable in treatment of diabetes. However, auto-immune diseases are thefastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) andInterleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.The major markets covered in this report are United States and Canada. The United States accountedfor the largest market of the North American injectable drug delivery technologies market in the year2012. However, Canada is expected to witness high growth due to growing prevalence of diabetes andautoimmune diseases such as multiple sclerosis and rheumatoid arthritis, increase in approval ofinjectable formulation and device, favorable reimbursement and rise in injectable cosmetic treatments.The growth of the injectable drug delivery technologies market is driven by factors such as innovationsin injectable drug delivery devices, rising prevalence of diabetes in the U.S. and Canada, improvingpatient compliance and rise in partnerships, collaborations and acquisitions among prominent players inthis market. However, factors such as product recalls, regulatory hurdles for approval of new devicesand formulations and needle-stick injuries and infections, are restraining the growth of the market.Injectable Drug Delivery Technologies Market, By SegmentInjectable Drug Delivery Devices TechnologiesInjectable Drug Delivery Formulations TechnologiesInjectable Drug Delivery Devices Technologies Market, By Product
  3. 3. About ReportsnReportsReportsnReports.com is your single source for all market research needs. Our database includes 250,000+syndicated market research reports from 100+ leading global publishers covering in-depth analysis of over 5000micro markets. With comprehensive information about the publishers and their report methodology, data sources,etc. we help you in your purchase decision by mapping your information needs with the most relevant availablereports in our library. Connect with us: sales@reportsandreports.com + 1 888 391 5441 Contact: sales@reportsandreports.com for further information.

×